Intracellular route and mechanism of action of ERB-hRNase, a human anti-ErbB2 anticancer immunoagent

FEBS Letters

Volumn 581, Issue 2, 2007, Pages 296-300

  Lorenzo, Claudia De ^a   Di Malta, Chiara ^a   Calì, Gaetano ^a   Troise, Fulvia ^a   Nitsch, Lucio ^a   D'Alessio, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

ErbB2; Immunotherapy; Immunotoxins; RNase; RNase inhibitor; scFv

Indexed keywords

ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; ERB HUMAN RIBONUCLEASE; ERBICIN; HUMAN ERBB2 IMMUNORIBONUCLEASE ANTIBODY; HUMAN PANCREATIC RIBONUCLEASE; RIBONUCLEASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; DRUG BINDING; DRUG CYTOTOXICITY; DRUG MECHANISM; ENDOSOME; ENZYME ACTIVITY; ENZYME INHIBITOR INTERACTION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PRIORITY JOURNAL;

EID: 33846216043     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.12.034     Document Type: Article

References (15)

1. Pastan I., and FitzGerald D. Recombinant toxins for cancer treatment. Science 254 (1991) 1173-1177
2. De Lorenzo C., Arciello A., Cozzolino R., Palmer D.B., Laccetti P., Piccoli R., and D'Alessio G. A fully human antitumor immunoRNase selective for ErbB-2-positive carcinomas. Cancer Res. 64 (2004) 4870-4874
3. De Lorenzo C., Palmer D.B., Piccoli R., Ritter M.A., and D'Alessio G. A new human antitumor immunoreagent specific for ErbB2. Clin. Cancer Res. 8 (2002) 1710-1719
4. Russo N., de Nigris M., Ciardiello A., Di Donato A., and D'Alessio G. Expression in mammalian cells, purification and characterization of recombinant human pancreatic ribonuclease. FEBS Lett. 333 (1993) 233-237
5. Landre J.B., Hewett P.W., Olivot J.M., Friedl P., Ko Y., Sachinidis A., and Moenner M. Human endothelial cells selectively express large amounts of pancreatic-type ribonuclease (RNase 1). J. Cell Biochem. 86 (2002) 540-552
6. Dickson K.A., Haigis M.C., and Raines R.T. Ribonuclease inhibitor: structure and function. Prog. Nucleic Acid Res. Mol. Biol. 80 (2005) 349-374
7. Newton D.L., Nicholls P.J., Rybak S.M., and Youle R.J. Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv. J. Biol. Chem. 269 (1994) 26739-26745
8. Bartholeyns J., Wang D., Blackburn P., Wilson G., Moore S., and Stein W.H. Explanation of the observation of pancreatic ribonuclease activity at pH 4.5. Int. J. Pept. Protein Res. 10 (1977) 172-175
9. Naddeo M., Vitagliano L., Russo A., Gotte G., D'Alessio G., and Sorrentino S. Interactions of the cytotoxic RNase A dimers with the cytosolic ribonuclease inhibitor. FEBS Lett. 579 (2005) 2663-2668
10. Donadio S., Tamburrini M., Di Donato A., Piccoli R., and D'Alessio G. Site-directed alkylation and site-site interactions in bovine seminal ribonuclease. Eur. J. Biochem. 157 (1986) 475-480
11. De Lorenzo C., Cozzolino R., Carpentieri A., Pucci P., Laccetti P., and D'Alessio G. Biological properties of a human compact anti-ErbB2 antibody. Carcinogenesis 26 (2005) 1890-1895
12. Gentile F., Cali G., Zurzolo C., Corteggio A., Rosa P., Calegari F., Levi A., Possenti R., Puri C., Tacchetti C., and Nitsch L. The neuroendocrine protein VGF is sorted into dense-core granules and is secreted apically by polarized rat thyroid epithelial cells. Exp. Cell Res. 295 (2004) 269-280
13. Mu F.T., Callaghan J.M., Steele-Mortimer O., Stenmark H., Parton R.G., Campbell P.L., McCluskey J., Yeo J.P., Tock E.P., and Toh B.H. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif. J. Biol. Chem. 270 (1995) 13503-13511
14. Lord J.M., and Roberts L.M. Toxin entry: retrograde transport through the secretory pathway. J. Cell Biol. 140 (1998) 733-736
15. Mellman I., Fuchs R., and Helenius A. Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 55 (1986) 663-700